Close Menu

NEW YORK – Personalis reported after the close of the market on Wednesday that its fourth quarter revenues rose 38 percent year over year, driven by an increase in testing volume and analytical services provided to the US Department of Veterans Affairs Million Veteran Program (VA MVP).

For the three months ended Dec. 31, the cancer genomics company reported revenues of $18.2 million, up from $13.2 million a year earlier, and beating the average Wall Street estimate of $17.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.